STOCK TITAN

[8-K] Biofrontera Inc. Warrants Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

iShares BB Rated Corporate Bond ETF, a series of iShares Trust, filed its routine Form NPORT-P for the monthly period ended 30-Apr-2025.

The fund reported total assets of $286.0 million, liabilities of $81.6 million, and net assets of $204.4 million. No borrowings were outstanding and no controlled foreign corporations were used. Cash and cash equivalents not otherwise disclosed totaled $0.20 million.

Interest-rate DV01 exposure in U.S. dollars was modest, led by the 5-year bucket at $26.96 thousand; a 100-bp parallel shift (DV100) would change portfolio value by $5.17 million in the 5-year tenor. Credit-spread sensitivity shows the portfolio is predominately non-investment-grade, with a 5-year CS01 of $55.35 thousand.

The fund is active in securities lending: across 20 counterparties, securities on loan totaled roughly $38.8 million (≈19% of net assets). Largest borrowers include Barclays Bank plc (~$9.0 m), BNP Paribas Prime Brokerage (~$7.25 m) and RBC Capital Markets (~$6.30 m). The filing indicates that some counterparties provided non-cash collateral, though exact amounts were not disclosed.

No preferred stock is outstanding, and the filing does not indicate that this will be the fund’s final NPORT-P submission.

iShares BB Rated Corporate Bond ETF, una serie di iShares Trust, ha presentato il consueto modulo Form NPORT-P per il periodo mensile terminato il 30 aprile 2025.

Il fondo ha dichiarato attività totali pari a 286,0 milioni di dollari, passività per 81,6 milioni di dollari e attività nette per 204,4 milioni di dollari. Non risultano prestiti in essere né società controllate estere utilizzate. La liquidità e le equivalenti non altrimenti indicate ammontano a 0,20 milioni di dollari.

L'esposizione DV01 al tasso d'interesse in dollari USA è modesta, con il segmento a 5 anni in testa con 26,96 mila dollari; uno spostamento parallelo di 100 punti base (DV100) modificherebbe il valore del portafoglio di 5,17 milioni di dollari nella scadenza a 5 anni. La sensibilità allo spread di credito indica che il portafoglio è prevalentemente non investment grade, con un CS01 a 5 anni pari a 55,35 mila dollari.

Il fondo è attivo nel prestito titoli: su 20 controparti, i titoli in prestito ammontano a circa 38,8 milioni di dollari (circa il 19% delle attività nette). I maggiori prenditori sono Barclays Bank plc (~9,0 milioni di dollari), BNP Paribas Prime Brokerage (~7,25 milioni di dollari) e RBC Capital Markets (~6,30 milioni di dollari). La dichiarazione indica che alcune controparti hanno fornito garanzie non in contanti, sebbene gli importi esatti non siano stati resi noti.

Non sono presenti azioni privilegiate in circolazione e la dichiarazione non indica che questa sarà l'ultima presentazione NPORT-P del fondo.

iShares BB Rated Corporate Bond ETF, una serie de iShares Trust, presentó su formulario rutinario Form NPORT-P para el período mensual finalizado el 30 de abril de 2025.

El fondo reportó activos totales por 286,0 millones de dólares, pasivos por 81,6 millones de dólares y activos netos por 204,4 millones de dólares. No había préstamos pendientes ni se usaron corporaciones extranjeras controladas. El efectivo y equivalentes no divulgados sumaron 0,20 millones de dólares.

La exposición DV01 a la tasa de interés en dólares estadounidenses fue modesta, liderada por el tramo a 5 años con 26,96 mil dólares; un desplazamiento paralelo de 100 puntos base (DV100) cambiaría el valor de la cartera en 5,17 millones de dólares en el plazo a 5 años. La sensibilidad al spread de crédito muestra que la cartera es predominantemente no investment grade, con un CS01 a 5 años de 55,35 mil dólares.

El fondo está activo en préstamos de valores: entre 20 contrapartes, los valores en préstamo totalizaron aproximadamente 38,8 millones de dólares (≈19% de los activos netos). Los mayores prestatarios incluyen Barclays Bank plc (~9,0 millones de dólares), BNP Paribas Prime Brokerage (~7,25 millones de dólares) y RBC Capital Markets (~6,30 millones de dólares). La presentación indica que algunas contrapartes proporcionaron colateral no en efectivo, aunque no se divulgaron las cantidades exactas.

No hay acciones preferentes en circulación y la presentación no indica que esta sea la última presentación NPORT-P del fondo.

iShares BB Rated Corporate Bond ETF, iShares Trust의 한 시리즈로, 2025년 4월 30일 종료된 월간 기간에 대한 정기 Form NPORT-P를 제출했습니다.

펀드는 총 자산 2억 8,600만 달러, 부채 8,160만 달러, 순자산 2억 440만 달러를 보고했습니다. 미지급 차입금은 없었으며, 통제 외국 법인도 사용하지 않았습니다. 별도로 공개되지 않은 현금 및 현금성 자산은 20만 달러였습니다.

미국 달러 기준 금리 DV01 노출은 적당하며, 5년 구간이 26,960달러로 가장 큽니다; 100bp 평행 이동(DV100)은 5년 만기 포트폴리오 가치를 517만 달러 변경시킬 수 있습니다. 신용 스프레드 민감도는 포트폴리오가 주로 비투자등급임을 보여주며, 5년 CS01은 55,350달러입니다.

이 펀드는 증권 대여에 적극적이며, 20개 거래 상대방을 통해 대여 중인 증권 총액은 약 3,880만 달러 (순자산의 약 19%)입니다. 주요 차입자는 Barclays Bank plc (~900만 달러), BNP Paribas Prime Brokerage (~725만 달러), RBC Capital Markets (~630만 달러)입니다. 제출서류에 따르면 일부 거래 상대방이 현금이 아닌 담보를 제공했으나 정확한 금액은 공개되지 않았습니다.

우선주는 발행되지 않았으며, 이번 제출이 펀드의 마지막 NPORT-P 제출이라는 내용은 포함되어 있지 않습니다.

iShares BB Rated Corporate Bond ETF, une série de iShares Trust, a déposé son formulaire NPORT-P habituel pour la période mensuelle close au 30 avril 2025.

Le fonds a déclaré des actifs totaux de 286,0 millions de dollars, des passifs de 81,6 millions de dollars et des actifs nets de 204,4 millions de dollars. Aucun emprunt n'était en cours et aucune société étrangère contrôlée n'a été utilisée. La trésorerie et les équivalents de trésorerie non autrement divulgués s'élèvent à 0,20 million de dollars.

L'exposition DV01 au taux d'intérêt en dollars américains était modeste, dominée par la tranche à 5 ans à 26,96 milliers de dollars ; un déplacement parallèle de 100 points de base (DV100) modifierait la valeur du portefeuille de 5,17 millions de dollars sur la maturité à 5 ans. La sensibilité au spread de crédit montre que le portefeuille est majoritairement non investment grade, avec un CS01 à 5 ans de 55,35 milliers de dollars.

Le fonds est actif dans le prêt de titres : auprès de 20 contreparties, les titres prêtés totalisent environ 38,8 millions de dollars (≈19 % des actifs nets). Les principaux emprunteurs sont Barclays Bank plc (~9,0 M$), BNP Paribas Prime Brokerage (~7,25 M$) et RBC Capital Markets (~6,30 M$). Le dépôt indique que certaines contreparties ont fourni des collatéraux non monétaires, bien que les montants exacts n'aient pas été divulgués.

Aucune action privilégiée n'est en circulation, et le dépôt n'indique pas que ce sera la dernière soumission NPORT-P du fonds.

iShares BB Rated Corporate Bond ETF, eine Serie der iShares Trust, reichte das routinemäßige Formular NPORT-P für den monatlichen Zeitraum zum 30. April 2025 ein.

Der Fonds meldete Gesamtvermögen von 286,0 Millionen US-Dollar, Verbindlichkeiten von 81,6 Millionen US-Dollar und Nettovermögen von 204,4 Millionen US-Dollar. Es gab keine ausstehenden Kredite und keine kontrollierten ausländischen Gesellschaften wurden genutzt. Nicht anderweitig ausgewiesene liquide Mittel und Zahlungsmitteläquivalente betrugen 0,20 Millionen US-Dollar.

Die Zins-DV01-Exposition in US-Dollar war moderat, angeführt vom 5-Jahres-Bucket mit 26,96 Tausend US-Dollar; eine parallele Verschiebung um 100 Basispunkte (DV100) würde den Portfoliowert im 5-Jahres-Zeitraum um 5,17 Millionen US-Dollar verändern. Die Kreditspread-Sensitivität zeigt, dass das Portfolio überwiegend Non-Investment-Grade ist, mit einem 5-jährigen CS01 von 55,35 Tausend US-Dollar.

Der Fonds ist aktiv im Wertpapierleihegeschäft: Bei 20 Gegenparteien beliefen sich die verliehenen Wertpapiere auf etwa 38,8 Millionen US-Dollar (≈19 % des Nettovermögens). Die größten Kreditnehmer sind Barclays Bank plc (~9,0 Mio. USD), BNP Paribas Prime Brokerage (~7,25 Mio. USD) und RBC Capital Markets (~6,30 Mio. USD). Die Einreichung weist darauf hin, dass einige Gegenparteien nicht-bargeldliche Sicherheiten gestellt haben, die genauen Beträge wurden jedoch nicht offengelegt.

Es sind keine Vorzugsaktien ausstehend, und die Einreichung gibt nicht an, dass dies die letzte NPORT-P-Einreichung des Fonds sein wird.

Positive
  • No outstanding borrowings, indicating the ETF is operating without balance-sheet leverage.
  • Diversified securities-lending counterparties (20 in total) reduce single-counterparty exposure risk while generating additional income potential.
Negative
  • Securities on loan equal to roughly 19 % of net assets, increasing counterparty and collateral-management risk.
  • High liability ratio (~28 % of total assets) mainly from lending activity may constrain liquidity in stressed markets.

Insights

TL;DR: Routine NPORT-P; $204 m net assets, no leverage, ~19 % on loan; risk metrics typical for BB-rated bond ETF.

The filing is largely administrative. The fund holds a moderate asset base without external borrowing, which limits structural leverage risk. Interest-rate DV01 and CS01 figures are in line with a diversified BB corporate-bond sleeve; the 5-year duration bucket dominates both rate and spread exposure, signalling sensitivity to mid-curve moves.

Securities lending is meaningful at nearly a fifth of NAV. While this can enhance income, it raises counterparty and reinvestment risk; nonetheless, collateral (cash and non-cash) mitigates first-loss risk. Liabilities represent roughly 28 % of assets, driven primarily by securities lending payables, but remain manageable given the absence of debt.

No red flags emerge—no going-concern language, no borrowings, and zero preferreds. Overall impact on investors is neutral; the report confirms expected portfolio characteristics without material surprises.

iShares BB Rated Corporate Bond ETF, una serie di iShares Trust, ha presentato il consueto modulo Form NPORT-P per il periodo mensile terminato il 30 aprile 2025.

Il fondo ha dichiarato attività totali pari a 286,0 milioni di dollari, passività per 81,6 milioni di dollari e attività nette per 204,4 milioni di dollari. Non risultano prestiti in essere né società controllate estere utilizzate. La liquidità e le equivalenti non altrimenti indicate ammontano a 0,20 milioni di dollari.

L'esposizione DV01 al tasso d'interesse in dollari USA è modesta, con il segmento a 5 anni in testa con 26,96 mila dollari; uno spostamento parallelo di 100 punti base (DV100) modificherebbe il valore del portafoglio di 5,17 milioni di dollari nella scadenza a 5 anni. La sensibilità allo spread di credito indica che il portafoglio è prevalentemente non investment grade, con un CS01 a 5 anni pari a 55,35 mila dollari.

Il fondo è attivo nel prestito titoli: su 20 controparti, i titoli in prestito ammontano a circa 38,8 milioni di dollari (circa il 19% delle attività nette). I maggiori prenditori sono Barclays Bank plc (~9,0 milioni di dollari), BNP Paribas Prime Brokerage (~7,25 milioni di dollari) e RBC Capital Markets (~6,30 milioni di dollari). La dichiarazione indica che alcune controparti hanno fornito garanzie non in contanti, sebbene gli importi esatti non siano stati resi noti.

Non sono presenti azioni privilegiate in circolazione e la dichiarazione non indica che questa sarà l'ultima presentazione NPORT-P del fondo.

iShares BB Rated Corporate Bond ETF, una serie de iShares Trust, presentó su formulario rutinario Form NPORT-P para el período mensual finalizado el 30 de abril de 2025.

El fondo reportó activos totales por 286,0 millones de dólares, pasivos por 81,6 millones de dólares y activos netos por 204,4 millones de dólares. No había préstamos pendientes ni se usaron corporaciones extranjeras controladas. El efectivo y equivalentes no divulgados sumaron 0,20 millones de dólares.

La exposición DV01 a la tasa de interés en dólares estadounidenses fue modesta, liderada por el tramo a 5 años con 26,96 mil dólares; un desplazamiento paralelo de 100 puntos base (DV100) cambiaría el valor de la cartera en 5,17 millones de dólares en el plazo a 5 años. La sensibilidad al spread de crédito muestra que la cartera es predominantemente no investment grade, con un CS01 a 5 años de 55,35 mil dólares.

El fondo está activo en préstamos de valores: entre 20 contrapartes, los valores en préstamo totalizaron aproximadamente 38,8 millones de dólares (≈19% de los activos netos). Los mayores prestatarios incluyen Barclays Bank plc (~9,0 millones de dólares), BNP Paribas Prime Brokerage (~7,25 millones de dólares) y RBC Capital Markets (~6,30 millones de dólares). La presentación indica que algunas contrapartes proporcionaron colateral no en efectivo, aunque no se divulgaron las cantidades exactas.

No hay acciones preferentes en circulación y la presentación no indica que esta sea la última presentación NPORT-P del fondo.

iShares BB Rated Corporate Bond ETF, iShares Trust의 한 시리즈로, 2025년 4월 30일 종료된 월간 기간에 대한 정기 Form NPORT-P를 제출했습니다.

펀드는 총 자산 2억 8,600만 달러, 부채 8,160만 달러, 순자산 2억 440만 달러를 보고했습니다. 미지급 차입금은 없었으며, 통제 외국 법인도 사용하지 않았습니다. 별도로 공개되지 않은 현금 및 현금성 자산은 20만 달러였습니다.

미국 달러 기준 금리 DV01 노출은 적당하며, 5년 구간이 26,960달러로 가장 큽니다; 100bp 평행 이동(DV100)은 5년 만기 포트폴리오 가치를 517만 달러 변경시킬 수 있습니다. 신용 스프레드 민감도는 포트폴리오가 주로 비투자등급임을 보여주며, 5년 CS01은 55,350달러입니다.

이 펀드는 증권 대여에 적극적이며, 20개 거래 상대방을 통해 대여 중인 증권 총액은 약 3,880만 달러 (순자산의 약 19%)입니다. 주요 차입자는 Barclays Bank plc (~900만 달러), BNP Paribas Prime Brokerage (~725만 달러), RBC Capital Markets (~630만 달러)입니다. 제출서류에 따르면 일부 거래 상대방이 현금이 아닌 담보를 제공했으나 정확한 금액은 공개되지 않았습니다.

우선주는 발행되지 않았으며, 이번 제출이 펀드의 마지막 NPORT-P 제출이라는 내용은 포함되어 있지 않습니다.

iShares BB Rated Corporate Bond ETF, une série de iShares Trust, a déposé son formulaire NPORT-P habituel pour la période mensuelle close au 30 avril 2025.

Le fonds a déclaré des actifs totaux de 286,0 millions de dollars, des passifs de 81,6 millions de dollars et des actifs nets de 204,4 millions de dollars. Aucun emprunt n'était en cours et aucune société étrangère contrôlée n'a été utilisée. La trésorerie et les équivalents de trésorerie non autrement divulgués s'élèvent à 0,20 million de dollars.

L'exposition DV01 au taux d'intérêt en dollars américains était modeste, dominée par la tranche à 5 ans à 26,96 milliers de dollars ; un déplacement parallèle de 100 points de base (DV100) modifierait la valeur du portefeuille de 5,17 millions de dollars sur la maturité à 5 ans. La sensibilité au spread de crédit montre que le portefeuille est majoritairement non investment grade, avec un CS01 à 5 ans de 55,35 milliers de dollars.

Le fonds est actif dans le prêt de titres : auprès de 20 contreparties, les titres prêtés totalisent environ 38,8 millions de dollars (≈19 % des actifs nets). Les principaux emprunteurs sont Barclays Bank plc (~9,0 M$), BNP Paribas Prime Brokerage (~7,25 M$) et RBC Capital Markets (~6,30 M$). Le dépôt indique que certaines contreparties ont fourni des collatéraux non monétaires, bien que les montants exacts n'aient pas été divulgués.

Aucune action privilégiée n'est en circulation, et le dépôt n'indique pas que ce sera la dernière soumission NPORT-P du fonds.

iShares BB Rated Corporate Bond ETF, eine Serie der iShares Trust, reichte das routinemäßige Formular NPORT-P für den monatlichen Zeitraum zum 30. April 2025 ein.

Der Fonds meldete Gesamtvermögen von 286,0 Millionen US-Dollar, Verbindlichkeiten von 81,6 Millionen US-Dollar und Nettovermögen von 204,4 Millionen US-Dollar. Es gab keine ausstehenden Kredite und keine kontrollierten ausländischen Gesellschaften wurden genutzt. Nicht anderweitig ausgewiesene liquide Mittel und Zahlungsmitteläquivalente betrugen 0,20 Millionen US-Dollar.

Die Zins-DV01-Exposition in US-Dollar war moderat, angeführt vom 5-Jahres-Bucket mit 26,96 Tausend US-Dollar; eine parallele Verschiebung um 100 Basispunkte (DV100) würde den Portfoliowert im 5-Jahres-Zeitraum um 5,17 Millionen US-Dollar verändern. Die Kreditspread-Sensitivität zeigt, dass das Portfolio überwiegend Non-Investment-Grade ist, mit einem 5-jährigen CS01 von 55,35 Tausend US-Dollar.

Der Fonds ist aktiv im Wertpapierleihegeschäft: Bei 20 Gegenparteien beliefen sich die verliehenen Wertpapiere auf etwa 38,8 Millionen US-Dollar (≈19 % des Nettovermögens). Die größten Kreditnehmer sind Barclays Bank plc (~9,0 Mio. USD), BNP Paribas Prime Brokerage (~7,25 Mio. USD) und RBC Capital Markets (~6,30 Mio. USD). Die Einreichung weist darauf hin, dass einige Gegenparteien nicht-bargeldliche Sicherheiten gestellt haben, die genauen Beträge wurden jedoch nicht offengelegt.

Es sind keine Vorzugsaktien ausstehend, und die Einreichung gibt nicht an, dass dies die letzte NPORT-P-Einreichung des Fonds sein wird.

false 0001858685 0001858685 2025-06-30 2025-06-30 0001858685 BFRI:CommonStockParValue0.001PerShareMember 2025-06-30 2025-06-30 0001858685 BFRI:PreferredStockPurchaseRightsMember 2025-06-30 2025-06-30 0001858685 BFRI:WarrantsToPurchaseCommonStockMember 2025-06-30 2025-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 30, 2025

 

Biofrontera Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40943   47-3765675
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

120 Presidential Way, Suite 330

Woburn, Massachusetts

  01801
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (781) 245-1325

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange
on which registered
Common stock, par value $0.001 per share   BFRI   The Nasdaq Stock Market LLC
Preferred Stock Purchase Rights       The Nasdaq Stock Market LLC
Warrants to purchase common stock   BFRIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (the “Exchange Act”) (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On June 30, 2025, Biofrontera Inc. issued a press release announcing the signing of an agreement to restructure its relationship with Biofrontera AG backed by an investment of $11 million led by existing investors, a copy of which is attached here as Exhibit 99.1.

 

The information in Item 7.01 of this Current Report is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

 

Item 9.01 Financial Statements and Exhibits.

 

99.1 Press release dated June 30, 2025
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

June 30, 2025

(Date)

Biofrontera Inc.

(Registrant)

  /s/ E Fred Leffler, III
 

E Fred Leffler, III

Chief Financial Officer

 

 

 

FAQ

What are the net assets reported by iShares BB Rated Corporate Bond ETF (USBF) for 30-Apr-2025?

$204.44 million in net assets.

How much total exposure does the ETF have to securities lending?

Approximately $38.8 million in securities are on loan across 20 counterparties.

Did the filing report any fund borrowings or debt?

No, the ETF shows $0 borrowings from banks, affiliates, or others.

Which counterparty has the largest securities-lending position with USBF?

Barclays Bank PLC with about $9.02 million in securities on loan.

What is the largest interest-rate risk bucket (DV01) for the portfolio?

The 5-year maturity bucket with a DV01 of $26.96 thousand.
Biofrontera

NASDAQ:BFRIW

BFRIW Rankings

BFRIW Latest News

BFRIW Latest SEC Filings

BFRIW Stock Data

1.49M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
WOBURN